Elevated Plasma Levels of MMP-12 Are Associated With Atherosclerotic Burden and Symptomatic Cardiovascular Disease in Subjects With Type 2 Diabetes
about
Matrix Metalloproteinases and Subclinical Atherosclerosis in Chronic Kidney Disease: A Systematic ReviewSynthesis and in Vitro and in Vivo Evaluation of MMP-12 Selective Optical ProbesVascular proteomics in metabolic and cardiovascular diseasesNovel biomarkers for cardiovascular risk prediction.Effect of food intake on 92 biomarkers for cardiovascular disease.LncRNA GAS5 is a critical regulator of metastasis phenotype of melanoma cells and inhibits tumor growth in vivo.Impact of Diabetes Mellitus.Matrix metalloproteinase-3 gene promoter polymorphisms: A potential risk factor for pelvic organ prolapse.The prediction of late-onset preeclampsia: Results from a longitudinal proteomics study.Integrative studies implicate matrix metalloproteinase-12 as a culprit gene for large-artery atherosclerotic stroke.Atherosclerotic plaque vulnerability in the statin era.Siglec-5 is a novel marker of critical limb ischemia in patients with diabetes.Interleukin-18, matrix metalloproteinase-22 and -29 are independent risk factors of human coronary heart disease.Circulating matrix metalloproteinases are associated with arterial stiffness in patients with type 1 diabetes: pooled analysis of three cohort studies.Fibrin(ogen) drives repair after acetaminophen-induced liver injury via leukocyte αMβ2 integrin-dependent upregulation of Mmp12.Highlighting Diabetes Mellitus: The Epidemic Continues.Elevated 20-HETE in metabolic syndrome regulates arterial stiffness and systolic hypertension via MMP12 activation.Killing Me Unsoftly: Causes and Mechanisms of Arterial Stiffness.Hyperglycemia does not affect tissue repair responses in shear stress-induced atherosclerotic plaques in ApoE-/- mice.
P2860
Q26752715-F1C08C8E-0A11-44F8-9F60-EF7A2A6915C8Q27727742-7AF410DB-5155-4EC9-85E9-91C6563A507FQ28070315-36F0026F-86CC-45F6-930B-42FB76E44C08Q33615459-AFF109A1-5AB6-4D9B-8A78-B7837332B382Q33769171-5E86AC4E-3464-47A2-AEA0-870E7B18643EQ37078557-B69499B5-9957-4D1B-96D2-EDF473CEF6BEQ37149768-4FFD8573-5522-4D8F-8339-AEEDF38AC02CQ37204140-DCF7B2C4-515F-403F-9FB2-4E6E82AFB9DBQ38664824-9CF55609-64F5-4663-ADCE-1B061F19366AQ40112560-69DD4EFB-C9B1-4DE1-BF09-E41371D4EA7EQ40260623-0AAB5F0E-54A6-4B59-8BD6-13E224B8BF2EQ41200652-A11BDAFF-3AE9-4A0E-9D4C-1FF51DDAEC2AQ41477536-90AF1F00-BD87-485E-BE2A-DFFB47AEB01EQ42627682-A2EFB364-68BA-40E5-8DC6-465F691FA9B2Q46446477-FAD8EB62-A47F-4648-88E7-5F5C5BA207AAQ49547709-22ECC282-5DBD-4AB8-96EE-EE530E82E246Q50081720-D46E3371-8D85-4D75-87F7-A3D8D38D2AA7Q50208698-60BA7B86-053B-4173-B383-D58CB717787BQ55355643-3AA58A74-DD59-4CB8-A8AD-742C345B5C75
P2860
Elevated Plasma Levels of MMP-12 Are Associated With Atherosclerotic Burden and Symptomatic Cardiovascular Disease in Subjects With Type 2 Diabetes
description
im Mai 2015 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 07 May 2015
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в липні 2015
@uk
name
Elevated Plasma Levels of MMP- ...... Subjects With Type 2 Diabetes
@en
Elevated Plasma Levels of MMP- ...... Subjects With Type 2 Diabetes
@nl
type
label
Elevated Plasma Levels of MMP- ...... Subjects With Type 2 Diabetes
@en
Elevated Plasma Levels of MMP- ...... Subjects With Type 2 Diabetes
@nl
prefLabel
Elevated Plasma Levels of MMP- ...... Subjects With Type 2 Diabetes
@en
Elevated Plasma Levels of MMP- ...... Subjects With Type 2 Diabetes
@nl
P2093
P50
P921
P1476
Elevated Plasma Levels of MMP- ...... Subjects With Type 2 Diabetes
@en
P2093
Carlo Palombo
Elena Venturi
Eva Bengtsson
Fiona Adams
Gerd Östling
Gunilla Nordin Fredrikson
Helen C Looker
Jan Nilsson
Kim Gooding
Kunihiko Aizawa
P304
P356
10.1161/ATVBAHA.115.305631
P407
P50
P577
2015-05-07T00:00:00Z